insights_auto
Outlook: 67.6% bullish·0.0% bearish
Go to analysischevron_right
SMMT:NASDAQ
Summit Therapeutics Inc
$17.31
arrow_upward
+0.23%(+0.040) 1D
$17.15
arrow_downward
-0.92% (-0.16)todayPre-market
Closed: Oct 6, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SMMT...
Open
$17.49
High
$17.53
Low
$16.53
Mkt. cap
13.10B
Avg. vol.
7.13M
Volume
3.77K
52-wk high
$29.23
52-wk low
$12.07
EPS
-$1.12
Beta
-1.51
Shares outstanding
797.75M
No. of employees
61
Open
$17.49
High
$17.53
Low
$16.53
Mkt. cap
13.10B
Avg. vol.
7.13M
Volume
3.77K
52-wk high
$29.23
52-wk low
$12.07
EPS
-$1.12
Beta
-1.51
Shares outstanding
797.75M
No. of employees
61
News stories
From web sources and news partners
Stock Titan
·
11 hours ago
A $2B financing leads Summit Therapeutics (SMMT) to ask investors for more authorized shares.
Benzinga
·
1 day ago
Amazon, Alphabet, Tesla Stock Rises: Robinhood Traders Sell Anyway
grafa.com
·
1 day ago
Summit Therapeutics Closes $2 Billion AstraZeneca Investment
About Summit Therapeutics Inc
CEO-
Employees61
FoundedAug 4, 2004
Headquarters-
Sector-
Website-